These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27725113)

  • 21. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatment.
    Pham HPT; Saroukhani S; Lindsey JW
    Mult Scler Relat Disord; 2023 Feb; 70():104497. PubMed ID: 36603289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of high-dose vitamin D
    Røsjø E; Lossius A; Abdelmagid N; Lindstrøm JC; Kampman MT; Jørgensen L; Sundström P; Olsson T; Steffensen LH; Torkildsen Ø; Holmøy T
    Mult Scler; 2017 Mar; 23(3):395-402. PubMed ID: 27325604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
    Kvistad S; Myhr KM; Holmøy T; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Løken-Amsrud KI; Lilleås F; Midgard R; Njølstad G; Pedersen T; Benth JŠ; Wergeland S; Torkildsen O
    Mult Scler; 2014 Dec; 20(14):1833-40. PubMed ID: 24842958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
    Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
    Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
    J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
    Lindsey JW; Khan U; Ansari W; Powell T; Wang YH; Guirguis MS
    J Neuroimmunol; 2013 Jan; 254(1-2):146-53. PubMed ID: 23026221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.
    Lindsey JW; deGannes SL; Pate KA; Zhao X
    Mol Immunol; 2016 Jan; 69():7-12. PubMed ID: 26637929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Dwyer DE; Taylor J; Blizzard L; Ponsonby AL; Pittas F; Dwyer T; van der Mei I
    Mult Scler; 2012 Jun; 18(6):799-806. PubMed ID: 22084489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis.
    Lindsey JW; Hatfield LM; Vu T
    Eur J Neurol; 2010 Oct; 17(10):1263-9. PubMed ID: 20402753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
    Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.
    Sundström P; Juto P; Wadell G; Hallmans G; Svenningsson A; Nyström L; Dillner J; Forsgren L
    Neurology; 2004 Jun; 62(12):2277-82. PubMed ID: 15210894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiple sclerosis and Epstein-Barr virus : new developments and perspectives].
    Ruprecht K
    Nervenarzt; 2008 Apr; 79(4):399-407. PubMed ID: 17713752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
    Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
    Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients.
    Villegas E; Santiago O; Carrillo JA; Sorlózano A; Guerrero M; Fernández O; Gutiérrez J
    Diagn Microbiol Infect Dis; 2011 May; 70(1):85-90. PubMed ID: 21388770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
    Wagner HJ; Munger KL; Ascherio A
    Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
    Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
    Comabella M; Kakalacheva K; Río J; Münz C; Montalban X; Lünemann JD
    Mult Scler; 2012 May; 18(5):605-9. PubMed ID: 22020417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.